This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Tyler Kennedy
Scientist, Gene Delivery Process and Analytical Development at Bristol Myers Squibb
Speaker

Profile

Tyler Kennedy is a Scientist in Gene Delivery Process and Analytical Development (GDPAD) at Bristol Myers Squibb where he is currently a downstream program lead focused on pre-clinical AAV process development, scale-up, and process transfer. Over his six years in GDPAD, Tyler and his team have developed purification strategies for both LVV and AAV programs, and successfully scaled and transferred these processes into GMP facilities. Tyler holds a Bachelor of Science in chemistry from the University of Washington and has spent 13 years in downstream process development.

Agenda Sessions

  • From a bench-scale rAAV platform process to GMP manufacturing: a look at how Tangential Flow Filtration (TFF) robustness and scaling impact successful process transfer

    4:00pm
  • From a bench-scale rAAV platform process to GMP manufacturing: a look at how Tangential Flow Filtration (TFF) robustness and scaling impact successful process transfer

    4:00pm

At this event